AnaptysBio, Inc.ANABNASDAQ

Revenue (LTM)

$235M

+157.0% YoY

Net Income (LTM)

$-13M

+90.9% YoY

Free Cash Flow

$20M

Revenue CAGR (5Y)

+25.6%

Marginsimproving

FCFTurned positive

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	63	10↓83.7%	17↑66.8%	91↑432.0%	235↑157.0%
Gross Profit	-35	-79↓122.3%	-115↓46.6%	-73↑37.0%	232↑420.0%
Operating Income	-57	-115↓102.7%	-164↓42.8%	-115↑30.1%	48↑141.7%
Net Income	-58	-129↓122.7%	-164↓27.1%	-145↑11.2%	-13↑90.9%
EBITDA	-56	-105↓89.0%	-156↓48.6%	-93↑40.7%	50↑154.3%
EPS Diluted	-2.11	-4.57↓116.6%	-6.08↓33.0%	-5.12↑15.8%	-0.46↑91.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	496	71↓85.6%	36↓49.6%	123↑242.2%	238↑93.5%
Total Current Assets	554	447↓19.3%	407↓9.0%	432↑6.2%	350↓18.9%
Total Assets	643	610↓5.1%	452↓25.9%	484↑7.0%	364↓24.7%
Total Current Liabilities	16	26↑61.8%	37↑43.7%	45↑21.3%	39↓15.0%
Total Liabilities	287	348↑21.5%	364↑4.6%	413↑13.4%	327↓20.8%
Total Equity	356	262↓26.5%	88↓66.4%	71↓19.6%	37↓47.5%
Total Debt	21	19↓7.2%	18↓8.4%	369↑1974.0%	14↓96.2%
Net Debt	-475	-52↑89.1%	-18↑65.0%	246↑1457.4%	-224↓190.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-46	-74↓60.3%	-121↓64.1%	-135↓12.0%	20↑114.6%
Capital Expenditure	-1	-0↑73.8%	-1↓125.4%	-0↑55.6%	-0↑75.7%
Free Cash Flow	-47	-74↓56.4%	-122↓64.4%	-136↓11.6%	20↑114.5%
Stock-Based Comp	15	27↑78.2%	33↑21.4%	34↑2.5%	36↑5.9%
Net Change in Cash	245	-424↓273.1%	-35↑91.7%	87↑346.5%	115↑32.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance